Recoxibright 120 Mg

Recoxibright 120 mg

Description:

Recoxibright 120 mg film-coated tablets is a prescription nonsteroidal anti-inflammatory drug (NSAID) containing etoricoxib, a selective COX-2 inhibitor (coxib). It is used for the relief of pain and inflammation associated with various musculoskeletal and joint disorders in adults. By selectively inhibiting cyclooxygenase-2 (COX-2), Recoxibright helps reduce the production of prostaglandins responsible for pain, swelling, and stiffness, while having less effect on COX-1 compared with traditional NSAIDs. It is intended for short-term and long-term management of inflammatory and degenerative joint diseases under medical supervision.

Indications:

• Treatment of osteoarthritis symptoms such as joint pain, stiffness, and reduced mobility.
• Treatment of rheumatoid arthritis to reduce pain, swelling, and joint inflammation.
• Treatment of psoriatic arthritis to relieve joint pain and inflammatory symptoms.
• Treatment of ankylosing spondylitis and other spondyloarthropathies to improve spinal pain and stiffness.
• Management of chronic low back pain of inflammatory or degenerative origin, as prescribed by a physician.
• Short-term treatment of acute pain conditions, such as musculoskeletal pain, post-traumatic pain, or post-operative pain, as directed by a doctor.
• Treatment of acute gouty arthritis to relieve intense joint pain, redness, and swelling during gout attacks.

Active Ingredients / Key Components:

• Etoricoxib – 120 mg per film-coated tablet (selective COX-2 inhibitor NSAID).
• Excipients: The full list of inactive ingredients (tablet core and coating components, such as fillers, binders, colorants, and stabilizers) is not available in the provided information. Please refer to the official package insert for a complete excipient list.

Dosage & Administration / How to Use:

• Recoxibright 120 mg should be used exactly as prescribed by your physician. Do not exceed the recommended dose or duration.
• Typical adult doses (for guidance only – always follow your doctor’s instructions):
  • Osteoarthritis: usually lower daily doses (e.g., 30–60 mg once daily are commonly used; 120 mg is generally not a routine chronic dose and may be reserved for specific indications as decided by the doctor).
  • Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis: typical doses are often 60–90 mg once daily; your doctor will determine if and when 120 mg is appropriate.
  • Acute gouty arthritis: 120 mg once daily for the shortest possible duration, usually up to a maximum of 8 days.
  • Acute pain conditions: dose and duration are individualized; 120 mg may be used short term under medical supervision.
• Swallow the tablet whole with water. Do not crush or chew.
• Recoxibright 120 mg can be taken with or without food. Taking it without food may result in a faster onset of action, while taking it with food may improve gastrointestinal tolerance.
• Use the lowest effective dose for the shortest duration necessary to control symptoms.
• If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed dose.
• Not recommended for children and adolescents under 16 years of age unless specifically directed by a specialist.

Clinical Benefits:

• Provides effective relief from inflammatory joint pain associated with osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
• Reduces swelling, tenderness, and stiffness in affected joints, helping to improve mobility and daily function.
• Offers targeted pain control in acute gout attacks, helping to quickly reduce intense joint pain and inflammation.
• Selective COX-2 inhibition provides anti-inflammatory and analgesic effects with reduced inhibition of COX-1 compared with non-selective NSAIDs, which may lower the risk of some gastrointestinal side effects (though risk is not eliminated).
• Once-daily dosing supports convenient pain management and improved adherence in chronic conditions.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to etoricoxib or any component of the formulation.
• Contraindicated in patients with active peptic ulcer, gastrointestinal bleeding, or a history of recurrent peptic ulcer/bleeding.
• Contraindicated in patients with severe hepatic impairment, severe renal impairment, or progressive kidney disease unless specifically advised by a specialist.
• Contraindicated in patients with established ischemic heart disease, cerebrovascular disease (e.g., stroke, TIA), or peripheral arterial disease, and in patients with uncontrolled hypertension.
• Use with extreme caution in patients with risk factors for cardiovascular disease (e.g., hypertension, hyperlipidemia, diabetes, smoking) and only under close medical supervision.
• Use with caution in patients with a history of gastrointestinal disorders (ulcer, bleeding, inflammatory bowel disease) and consider gastroprotective measures if needed.
• May cause fluid retention and edema; use cautiously in patients with heart failure, hypertension, or other conditions predisposed to fluid overload.
• May impair renal function, especially in dehydrated patients, elderly patients, or those taking diuretics, ACE inhibitors, or ARBs.
• Do not use concomitantly with other NSAIDs, including selective COX-2 inhibitors, unless directed by a physician.
• Consult your doctor before use if pregnant, planning pregnancy, or nursing. Etoricoxib is generally not recommended during pregnancy and breastfeeding.
• Consult your doctor before use if you have liver disease, kidney disease, heart disease, hypertension, history of stroke, bleeding disorders, or are taking anticoagulants, antiplatelet drugs, diuretics, or other chronic medications.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.
• Do not exceed the prescribed dose or duration, as prolonged or high-dose use may increase the risk of cardiovascular and gastrointestinal adverse events.

Side Effects:

• Common side effects may include headache, dizziness, fatigue, abdominal pain, indigestion, heartburn, nausea, diarrhea, flatulence, and peripheral edema (swelling of legs or ankles).
• Other possible side effects include increased blood pressure, palpitations, fluid retention, rash, itching, and mild elevation of liver enzymes.
• Serious side effects (seek immediate medical attention) may include chest pain, shortness of breath, sudden weakness or difficulty speaking (signs of heart attack or stroke), severe abdominal pain, black or bloody stools, vomiting blood, severe allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing), or severe skin reactions.
• If you experience unexplained weight gain, swelling, shortness of breath, severe headache, visual disturbances, or any unusual symptoms, stop the medication and contact your doctor immediately.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Prescription medicine – selective COX-2 inhibitor NSAID.
• Strength: 120 mg etoricoxib per film-coated tablet.
• Form: Film-coated tablet (f.c. tabs).
• Pack size: 7 film-coated tablets per pack (7 f.c. tabs).
• Route of administration: Oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.